It has been described that IL-6 and bone morphogenetic proteins (BMPs) control hepcidin secretion in different cancers such as breast and prostate cancers [33,119] and IL-6 levels were increased in lung cancer patients with poor prognosis [120]. This evidence concerns the gene IL6 and prostate carcinoma.